Bellevue Asset Management’s Zimmer Biomet ZBH Stock Holding History

Bellevue Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-337	Closed	-$36K	–	514
2022 Q2	$36K	Hold	337	–	–	0.03%	183
2022 Q1	$44K	Sell	337 -10	-3%	-$1.21K	0.03%	184
2021 Q4	$43K	Sell	347 -348	-50%	-$45.5K	0.03%	193
2021 Q3	$100K	Hold	695	–	–	0.06%	115
2021 Q2	$109K	Sell	695 -5	-0.7%	-$810	0.07%	112
2021 Q1	$109K	Hold	700	–	–	0.07%	112
2020 Q4	$108K	Buy	700 +5	+0.7%	+$706	0.07%	109
2020 Q3	$92K	Hold	695	–	–	0.06%	111
2020 Q2	$81K	Sell	695 -6,515	-90%	-$751K	0.08%	115
2020 Q1	$819K	Buy	+7,210	New	+$945K	0.85%	29

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bellevue Asset Management's ZBH Position: Q3 2022 in Review

Bellevue Asset Management sold out of Zimmer Biomet (ZBH) in Q3 2022, closing a stake of 337 shares — an estimated $36K sold.

Bellevue Asset Management first reported a position in ZBH in Q1 2020 and held it in 10 quarters. The position peaked at $819K in Q1 2020. 918 funds tracked by Wall St. Rank hold ZBH as of Q3 2022.

Bellevue Asset Management reported no remaining Zimmer Biomet position as of Q3 2022 after selling out during the quarter.
Bellevue Asset Management sold 337 Zimmer Biomet shares in Q3 2022, an estimated $36K.
Bellevue Asset Management first reported a position in Zimmer Biomet in Q1 2020 and held it in 10 quarters.
Bellevue Asset Management's Zimmer Biomet position peaked at $819K in Q1 2020.
918 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2022.

Based on Bellevue Asset Management's 13F filing for Q3 2022, filed 7 Nov 2022.